Jiangsu Hengrui Medicine Co., Ltd. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was CNY 23,288.576 million compared to CNY 17,417.901 million a year ago. Operating income was CNY 6,149.679 million compared to CNY 4,596.653 million a year ago. Net income was CNY 5,328.027 million compared to CNY 4,065.609 million a year ago. Basic earnings per share from continuing operations was CNY 1.2 compared to CNY 0.92 a year ago. Diluted earnings per share from continuing operations was CNY 1.2 compared to CNY 0.91 a year ago.